IRIS
SCILIPOTI, PIETRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 694
EU - Europa 511
AS - Asia 276
Continente sconosciuto - Info sul continente non disponibili 91
SA - Sud America 34
AF - Africa 10
Totale 1.616
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 636
IT - Italia 232
RU - Federazione Russa 214
SG - Singapore 93
CN - Cina 65
IN - India 40
CA - Canada 30
BD - Bangladesh 25
BR - Brasile 22
HK - Hong Kong 19
VN - Vietnam 16
DE - Germania 12
GB - Regno Unito 12
NL - Olanda 10
FR - Francia 7
PL - Polonia 7
ES - Italia 6
JM - Giamaica 6
CR - Costa Rica 5
GT - Guatemala 4
MY - Malesia 4
HN - Honduras 3
JP - Giappone 3
MX - Messico 3
TN - Tunisia 3
TR - Turchia 3
ZA - Sudafrica 3
AR - Argentina 2
CO - Colombia 2
EG - Egitto 2
FI - Finlandia 2
MD - Moldavia 2
UY - Uruguay 2
UZ - Uzbekistan 2
AG - Antigua e Barbuda 1
AL - Albania 1
AZ - Azerbaigian 1
BE - Belgio 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
ET - Etiopia 1
GY - Guiana 1
JO - Giordania 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
KR - Corea 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
NI - Nicaragua 1
NP - Nepal 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
SE - Svezia 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
UA - Ucraina 1
VE - Venezuela 1
Totale 1.525
Salva come PNG Salva come JPEG
Città #
Ashburn 81
Singapore 55
San Jose 49
Milan 46
Council Bluffs 35
Chennai 31
Moscow 30
New York 24
Rome 21
Hong Kong 19
North Bergen 17
Santa Clara 17
Phoenix 16
Beijing 15
Dallas 13
Modena 12
Los Angeles 11
Memphis 11
Naples 11
Miano 10
Chicago 9
Denver 8
Hanoi 8
Shanghai 8
Turin 8
Montreal 7
Atlanta 6
Boardman 5
Catania 5
Orem 5
Warsaw 5
Washington 5
Bari 4
Bengaluru 4
Bologna 4
Brooklyn 4
Buffalo 4
Hefei 4
Houston 4
Kingston 4
Monza 4
North Kansas City 4
Nuremberg 4
San Francisco 4
Toronto 4
Amsterdam 3
Florence 3
Guatemala City 3
Johannesburg 3
Kansas City 3
Lauterbourg 3
Manassas 3
Miami 3
Munich 3
San José 3
São Paulo 3
Acalanes Ridge 2
Ankara 2
Brescia 2
Carpi 2
Chianciano Terme 2
Columbia 2
Dhaka 2
Falkenstein 2
Frankfurt am Main 2
Guangzhou 2
Ho Chi Minh City 2
Las Vegas 2
London 2
Madrid 2
Manchester 2
Mumbai 2
New Delhi 2
New Orleans 2
Oudehaske 2
Oxford 2
Palermo 2
Peschiera Borromeo 2
Querétaro 2
Salvador 2
San Antonio 2
Shenzhen 2
Tashkent 2
Tokyo 2
Turku 2
Valencia 2
Venice 2
Verona 2
Winston-Salem 2
Wroclaw 2
Abakan 1
Abbeville 1
Abilene 1
Al Fayyum 1
Alajuela 1
Algoz 1
Amarillo 1
Ambler 1
Amman 1
Andradas 1
Totale 766
Salva come PNG Salva come JPEG
Nome #
Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy 152
Time for action: actinium-225 PSMA-targeted alpha therapy for metastatic prostate cancer – a systematic review and meta-analysis 147
Long-term functional outcomes in patients undergoing radical nephrectomy for renal cell carcinoma and tumor thrombus 135
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 135
External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography 116
Temporal trends and clinical determinants of urinary diversion after radical cystectomy 102
Tailored use of PSA density according to multiparametric MRI index lesion location: results of a large, multi-institutional series 97
Head-to-head comparison of nephrometry scores for partial nephrectomy: implications for clinical guidelines 93
Utility of MRI perilesional biopsy in prostate cancer: impact of the Prostate Imaging-Reporting and Data System and biopsy history 85
Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-Guérin (BCG) in BCG-naïve High-risk Non–muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC Trials 64
Identifying optimal candidates for active surveillance in low-grade intermediate-risk non-muscle invasive bladder cancer 30
Evaluating the Surrogacy of Pathological Complete Response at Radical Cystectomy in Neoadjuvant-based Muscle-invasive Bladder Cancer Trials 28
Re: Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non-muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk Dynamics 26
Surgical Management of PSMA PET-Positive Lymph Nodes in Prostate Cancer 26
Beyond surgical technique: modifiable risk factors and evolving treatment paradigms in bladder cancer surgery 26
Impact of BCG failure patterns on efficacy of intravesical gemcitabine/docetaxel in high-risk non-muscle-invasive bladder cancer 24
Management and recurrence patterns of radiation-induced cystitis with hematuria: a persistent clinical challenge 23
The Impact of Second Opinion Expert Pathology Review in Patient Management at the Time of Transurethral Resection of the Bladder 23
Optimizing oncological outcomes in high-grade non-muscle invasive bladder cancer: The impact of a surgeon-led treatment pathway 22
The value of maintenance therapy in intermediate-risk non-muscle-invasive bladder cancer 21
Serenoa Repens–Lycopene–Selenium and Epilobium–Palmitoylethanolamide–Calendula after transperineal prostate biopsy: a tertiary single center experience 20
Patient selection for prostate cancer focal therapy guided by mpMRI–PSMA PET concordance and pathology review 19
Real-world outcomes of bladder-sparing strategies for BCG-unresponsive non-muscle-invasive bladder cancer: a multicenter study 18
Gemcitabine and docetaxel for high-risk non-muscle-invasive bladder cancer: EuroGemDoce group results 16
Impact of timing between neoadjuvant therapy and radical cystectomy on survival in muscle-invasive bladder cancer 15
Corrigendum to “Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-Guérin (BCG) in BCG-naïve High-risk Non–muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC Trials”(European Urology, (2025), (S0302283825048778), 10.1016/j.eururo.2025.12.022) 15
The role of re-transurethral resection of bladder tumor in patients with TaHG non muscle invasive bladder cancer 14
Impact of Body Mass Index on Renal Function Impairment in Patients Treated for Renal Cell Carcinoma at High Risk of Recurrence: Key Implications for Systemic Therapy Eligibility 13
Prognostic Implications of Patients With Clinically Node Positive Bladder Cancer Undergoing Radical Cystectomy 13
Real-world impact of cisplatin-based neoadjuvant chemotherapy on bladder cancer survival: a 20-year study 12
Surrogacy of Intermediate Clinical Endpoints for Overall Survival in Patients With Localized Muscle-Invasive Bladder Cancer 12
Incidence and Predictors of Acute Kidney Injury and Acute Kidney Disease After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients 12
The Financial Burden of Localized and Metastatic Bladder Cancer 11
The impact of histopathological evaluation at transurethral resection of bladder tumour on survival in radical cystectomy candidates 11
Oncological Outcomes in Bacillus Calmette-Guérin-naïve High-risk Non-muscle-invasive Bladder Cancer Patients: A Systematic Review on Current Treatment Strategies and Future Perspectives 10
Outcomes of BCG vs upfront radical cystectomy for high-risk non-muscle-invasive bladder cancer 9
Comment to: "Oncologic outcomes of robot-assisted radical cystectomy for bladder carcinoma by urinary diversion type" 8
Risk of Metachronous Upper Tract Urothelial Carcinoma After Ureteral Stenting in Patients With Bladder Cancer 8
The Role of Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis 5
Totale 1.616
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.845
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.845
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20231 0 0 0 0 0 0 0 0 0 0 0 1
2023/202418 2 1 0 0 1 2 0 1 0 4 1 6
2024/202578 8 3 5 5 5 3 9 12 10 3 5 10
2025/2026746 23 19 16 50 68 27 54 74 191 57 114 53
2026/2027773 50 68 231 424 0 0 0 0 0 0 0 0
Totale 1.616